Topic: M&A

Boston Scientific (NYSE:BSX)+today announced it completed the acquisition of Apollo Endosurgery. The acquisition was announced in November and […]

Bain Capital has acquired Evident, the former scientific solutions division of Olympus, after receiving regulatory […]

HeartBeam (Nasdaq:BEAT) announced today that it acquired substantially all assets from Livmor, which develops remote monitoring technology. […]

Swedish medtech company Getinge announced today that it will pay SEK 170 million ($16 million) […]

Clues are pointing to Mozarc Medical as the name of the new kidney care company […]

Transcarent, a digital platform focused on the self-insured employer market, announced plans to acquire assets […]

Xtant Medical has acquired the Coflex and Cofix product lines from Surgalign for a total […]

Amazon closed its $3.9 billion acquisition of primary care provider One Medical shortly after multiple news outlets reported […]

Shockwave Medical (Nasdaq:SWAV) shares rose this morning on fourth-quarter results that came in ahead of the […]

A 2021 rumor that Globus Medical and NuVasive were trying to reach a deal has become reality in […]

Companion Spine has announced the acquisition of Backbone SAS, a company based in Bordeaux, France, […]

Garmin Navigates into ECG Space Garmin, once known for its GPS systems, is the latest […]

Tandem Diabetes has closed a deal that has the potential to significantly improve its diabetes […]

Medical device companies set the tone for 2023 at last week’s J.P. Morgan Healthcare Conference […]

CVS Health filled headlines during the J.P. Morgan conference in San Francisco this week through a series […]

LeanTaaS, a Silicon Valley-based company that sells capacity optimization software to healthcare providers, on Tuesday completed its […]

Ypsomed and Mediq announced today that they completed the sale of mail-order retailer for diabetes care […]

Baxter International has announced plans to spin off its renal care and acute therapies businesses […]

Orthofix Medical Inc and SeaSpine Holdings Corporation have announced the successful completion of their merger […]

Zimmer Biomet is already flexing its M&A muscles in 2023 with a deal valued at […]

Johnson & Johnson (NYSE:JNJ) announced today that it completed its $16.6 billion acquisition of Abiomed (Nasdaq:ABMD). Abiomed now […]

Olympus announced today that it agreed to acquire cloud-based AI endoscopy technology developer Odin Vision. The […]

Dive Brief: Ekso Bionics acquired Parker Hannifin’s Indego lower limb exoskeleton products and the other assets in its […]

Boston Scientific (NYSE:BSX) today announced it entered a definitive agreement to acquire Apollo Endosurgery (NSDQ:APEN) for more than […]

ASX-listed health tech firm CardieX announced it acquired Silicon Valley-based Blumio, a developer of cardiovascular sensor […]

SeaSpine CFO John Bostjancic will continue as the top financial officer of the to-be-named orthopedic […]

Acutus Medical (Nasdaq:AFIB) announced today that it completed the first milestone under its asset purchase agreement […]

Johnson & Johnson (NYSE:JNJ) announced today that it agreed to acquire Abiomed (Nasdaq:ABMD) for approximately $16.6 billion. Under […]

Orthofix and SeaSpine have entered into a definitive agreement to combine in an all-stock merger […]

Beckman Coulter Diagnostics’ latest acquisition has it swimming in the artificial intelligence side of the […]

Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in […]

InVivo Therapeutics (Nasdaq:NVIV) announced today that it entered into a definitive agreement to offer $9 million […]

LogicBio’s lead gene-editing therapy is emerging from a clinical hold, cash reserves to support that […]

Sanofi’s technology for making natural killer (NK) cell therapies came from an M&A move. The […]

Penumbra and Japanese medical device manufacturer Asahi Intecc will collaborate to launch the Indigo Aspiration System in Japan following receipt […]

Gene therapy developer Rocket Pharmaceuticals is on track to seek FDA approval for its lead […]

Advanced MedTech Holdings (AMTH or the Group) announced the acquisition of a majority interest in […]

Roche announced Wednesday that it is paying $250 million in cash to acquire Good Therapeutics, a Seattle-based preclinical biotech […]

Dive Brief: Olympus agreed to sell its microscope unit to private equity firm Bain Capital for 427.6 billion […]